Industries
Top countries
Publication dates
All regions
data types
industry reports
country reports
... Spondylitis) $21.9 Billion in 2005 (projected $35.5 Billion in 2010). Large market for natural anti-inflammatories 12 commercial drivers anti-inflammatories 2 Possibility to market as food ingredients ...
... Exhibited significant anti-arthritic activity as compared to other extracts. The doses of 200 mg/kg bw of the ethanolic extract of cleome rutidosperma, in chronic model of granuloma pouch in rats ...
... Exhibited significant anti-arthritic activity as compared to other extracts. The doses of 200 mg/kg bw of the ethanolic extract of cleome rutidosperma, in chronic model of granuloma pouch in rats ...
... Exists for cross-sensitivity to acetylsalicylic acid and other non-steroidal anti-inflammatory drugs. Acular is contra-indicated in individuals who have previously exhibited sensitivities to these drugs. 4 ...
... Conditions. These find- ings demonstrate that the oxidative capability of this microorganism for the anti-inflammatory drugs is not restricted to an oxygen environment, as generally accepted, since the fungal ...
... Exist in the ability of meloxicam to inhibit the biosynthesis of prostaglandins, known mediators of inflammation, by inhibition of cyclooxygenase (cox). Comparison of the ulcerogenic dose and the anti-inflammatory ...
... Enantiomer to (s)-enantiomer. It is known that the (s)-enantiomer supports the anti-inflammatory effect of ketoprofen. Irish medicines board ...
... Analgesic, anti-extive and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue. To a minor extent it also inhibits collagen-induced thrombocyte aggregation. In vitro and in vivo ...
... Systems and 33% of veal producers are mrsa positive.27 Also, there is a growing interest in the use of (non-)steroidal anti- inflammatory drugs [(n)saids] as an additional or replacement therapy ...
... As a preventive of gastroduodenal ulcers induced by non-selective non- steroidal anti-inflammatory drugs (nsaids) should be restricted to patients who require continued nsaid treatment and have an increased risk ...
» Purchase Premium Reports (From $ 99 - $ 11 400)
About 200 reports for Anti-inflammatory
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription. This report ...
» Read our Company Profiles
2 Companies for Anti-inflammatoryReportlinker.com © Copyright 2013. All rights reserved.